Insights

Better decisions begin with deeper understanding.

Explore the expertise, insights, and perspectives from OPEN Health that help transform complexity into clarity across today’s healthcare landscape.

Showing 190–198 of 1,050 insights

Two interconnected rings, one covered in shiny spheres and the other in soft, fuzzy texture, both in shades of pink and purple against a blurred gradient background.

Thought Leadership

The Top Five Themes of the ASH Annual Meeting

Real-world use of Ubrogepant as acute treatment for migraines

Publications

Real-world use of Ubrogepant as acute treatment for migraine with an anti-calcitonin gene-related peptide monoclonal antibody: results from COURAGE

Discrete choice experiment (DCE) to quantify trial features

Publications

Discrete choice experiment (DCE) to quantify the influence of trial features on the decision to participate in cystic fibrosis (CF) clinical trials

Microscopic view of stained human tissue showing irregularly shaped cells with prominent nuclei, indicative of cancer cells, possibly from a carcinoma biopsy.

Publications

Perspectives of healthcare professionals on the management and treatment of advanced ovarian cancer in the UK: results from the KNOW-OC survey

Hemolytic disease of the fetus and newborn

Publications

Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes

Epidemiology and burden of dengue fever in the United States

Publications

Epidemiology and burden of dengue fever in the United States: a systematic review

Caregiver preferences for juvenile idiopathic arthritis treatment

Publications

Adolescent and caregiver preferences for juvenile idiopathic arthritis treatment: a discrete-choice experiment

A doctor gently holds a patient's hand in a comforting gesture, with a stethoscope and clipboard visible in the background.

Publications

Opicapone versus entacapone: Head-to-head retrospective data-based comparison of healthcare resource utilization in people with Parkinson’s disease new to catechol-O-methyltransferase (COMT) inhibitor treatment

A transparent blue human skull with the top of the brain area highlighted in bright pink, illustrating pain or injury in the upper head region.

Publications

Evaluating therapeutic benefits of ubrogepant via latent class models: A post hoc exploratory analysis of the ACHIEVE I and ACHIEVE II trials